机构：[1]Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, China河北医科大学第四医院[2]Department of General Surgery I, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China[3]Department of Center for Breast Diseases, Peking University First Hospital, Beijing 100034, China.
第一作者机构：[1]Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, China[2]Department of General Surgery I, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China[*1]Department of Breast Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050035, China[*2]Department of General Surgery I, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China
推荐引用方式(GB/T 7714)：
Li Ma,Zhi-Cheng Ge,Ling Xin,et al.Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021.[J].CHINESE MEDICAL JOURNAL.2021,134(16):1894-1896.doi:10.1097/CM9.0000000000001522.
APA：
Li Ma,Zhi-Cheng Ge,Ling Xin,Ying-Xin Wang,Yan-Shou Zhang...&Chinese Society of Breast Surgery.(2021).Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021..CHINESE MEDICAL JOURNAL,134,(16)
MLA：
Li Ma,et al."Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021.".CHINESE MEDICAL JOURNAL 134..16(2021):1894-1896
